Register
Login:
Share:
Email Facebook Twitter

Add Summit Corp to quick picks

Summit Corp Share Price (SUMM)



Share Price Information for Summit Corp (SUMM)


Share Price: 128.50Bid: 127.00Ask: 130.00Change: 3.50 (+2.80%)Riser - Summit Corp
Spread: 3.00Spread as %: 2.36%Open: 125.00High: 128.50Low: 124.50Yesterday’s Close: 125.00

Summit Corporation Plc Ord 1P

Summit Corp is listed in the FTSE AIM All-Share
Summit Corp is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
128.50

Share Price SpacerBid
127.00

Share Price SpacerAsk
130.00

Share Price SpacerChange
2.80%3.50

Share Price SpacerVolume
55,882

Share Price SpacerOpen
125.00

Share Price SpacerHigh
128.50

Share Price SpacerLow
124.50

Share Price SpacerClose
125.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 41.06m £52.76m 2,500

52 Week High 178.00 52 Week High Date 15-SEP-2014
52 Week Low 6.25 52 Week Low Date 27-MAY-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
18 18,682 31,500 -4.312 -29.80 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

24-Oct-14
13:09:34
127.30
416
Sell* 
127.00
130.00
529.57
Trade Type:
Ordinary

24-Oct-14
13:04:34
127.33
864
Sell* 
127.00
130.00
1,100
Trade Type:
Ordinary

24-Oct-14
12:08:57
130.00
2,500
Buy* 
125.00
130.00
3,250
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Summit Corp trades >>

Directors Deals for Summit Corp (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
29-Jul-14Buy
Trade Notifier Information for Summit Corporation
Glyn Edwards held the position of CEO at Summit Corporation at the time of this trade.
 Glyn Edwards
104.5GBX30,000233333
23-Jul-13Placing
Trade Notifier Information for Summit Corporation
Frank Armstrong held the position of Non-Executive Director at Summit Corporation at the time of this trade.
 Frank Armstrong
5GBX50,00050000
23-Jul-13Placing
Trade Notifier Information for Summit Corporation
Jim Mellon held the position of Non-Executive Director at Summit Corporation at the time of this trade.
 Jim Mellon
5GBX20,000,00045000001
View more Summit Corp directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Today 11:35
GP68
Activity
124.50
Strong Buy

Looks like a little more healthy activity today. I couldn't resist a small purchase of 1500 shares at £1.26 and was pleased to see a purchase of 15000 at the same price shortly after mine. As I said yesterday feels like we could have bottomed out at this level again. Good luck everyone, we are getting ever closer to news I feel.
Thu 15:42
GP68
Chrisatrdg
125.50
Strong Buy

Chrisatrdg..Thank you for that..not a huge story but something to learn about one of our larger shareholders. The 1share trade today, is it a signal that an RNS is coming in the morning, will be tested. I personally do not believe it but you never know. Got back to the recent low once again..wont be long till se get some uplift I feel. Getting closer and closer to news from across the water on C Difficile. I reminded my self today that in this form the price got to £4 last year..so many good RNS's since just does not make sense. But it does tell me that any good news from C Diff and we will absolutely fly. GL
Thu 14:10
Chrisatrdg
Richard Griffiths contd
125.50
Hold

Daily Mail extract 'Entrepreneur and major 17 per cent shareholder Richard Griffiths pulled off a coup when he installed Chris Richards as non-executive chairman of Plant Health Care in August 2012. He’d already enjoyed a distinguished career in the global agrochemical industry and was instrumental in transforming Arysta LifeScience into a global agrochemical company with one of the fastest growth rates in the industry with sales above £1billion. His appointment escaped the market’s notice, that is until yesterday. Dealers heard that Arysta LifeScience had succumbed to an agreed £2.24billion offer from Platform Specialty Products backed by London-based private equity firm, Permira. The news prompted hopes that Richards will now weave his magic at Plant Health Care and transform it into an attractive takeover target. Buyers piled in and the close was 6.6p or 9 per cent higher at a year’s peak of 81.5p. Richards put his money where his mouth is in April when he bought another 5,000 shares at 59p which increased his shareholding to 61,500. His buying will probably not stop there as he builds the company up into an attractive takeover target.'
Thu 09:25
GP68
Richard Griffiths
125.50
Strong Buy

Article in the Daily Mail market report section about entrepreneur Richard Griffiths dealings with another pharmaceutical company. Looks like a pretty shrewd cookie to me.Not able to copy over to this board unfortunately. RG had 5.15% of Summit at the last count I believe. GL
Wed 17:04
Chrisatrdg
Current position
125.50
Hold

Hi All - The next phase for DMD post phase 1b is due to start by December so not yet overdue. With regards what are they doing and the time taken I expect that they need to ensure that all is correct by dotting the i's and crossing the t's as they cannot afford for the pre phase 2 trial not to work this time. As someone said earlier 'keep the faith' and remember that c-diff is at stage 2 which if the trials work will have a significant effect on the SP. GLA
Wed 13:55
Rhines
RE: ????????????
125.00
No Opinion

Yes targets slipping seems to be the norm, I haven't double checked but sure we were expecting some news by now on the DMD Phase 1B trial. I don't have a medical background so it's very difficult to understand why it takes so long to address a dietary issue, there would appear to be no shortage of patients willing to take part in the trials (understandably). Hopefully news soon.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Summit Corp (SUMM) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs




Sign up for Live Prices


CD02WL.001.081313
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.